Page last updated: 2024-08-21

cyproterone acetate and Venous Thrombosis

cyproterone acetate has been researched along with Venous Thrombosis in 18 studies

Research

Studies (18)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	14 (77.78)	29.6817
2010's	4 (22.22)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Rosendaal, FR; van Hylckama Vlieg, A	1
Arnold, JD; Coleman, ME; Goldstein, DA; Sarkodie, EP	1
Amoura, Z; Blétry, O; Chabbert-Buffet, N; Frances, C; Galicier, L; Gompel, A; Lévy, DP; Piette, JC; Scarabin, PY; Wechsler, B	1
Aksoy, ON; Cakir, O; Colak, N; Nazli, Y	1
Wooltorton, E	1
de Vries, CS; Farmer, RD; Seaman, HE	2
Ford, AR; Lexchin, J; Lippman, A; Mintzes, B	1
Rowe, TC	1
Lidegaard, Ø	1
Spitzer, WO	2
Gooren, LJ; Magdeleyns, EJ; Rosing, J; Tans, G; Thomassen, MC; Toorians, AW; Zweegman, S	1
Meltzer, A	1
Beasley, R; Henderson, M; Heuser, P; Hopkins, R; Metcalfe, S; Tonga, K; Weatherall, M	1
de Vries, CS; Farmer, RD; Langley, SE; Seaman, HE	1
Carpentier, S; Francès, C; Gompel, A; Piette, JC	1
Milsom, I; Odlind, V; Persson, I; Victor, A	1

Reviews

1 review(s) available for cyproterone acetate and Venous Thrombosis

Article	Year
Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2003, Volume: 25, Issue:12 Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Cyproterone Acetate; Epidemiologic Studies; Estrogens; Ethinyl Estradiol; Female; Humans; Incidence; Middle Aged; Risk Assessment; Risk Factors; Thromboembolism; Venous Thrombosis	2003

Article

Year

Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2003, Volume: 25, Issue:12

Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Cyproterone Acetate; Epidemiologic Studies; Estrogens; Ethinyl Estradiol; Female; Humans; Incidence; Middle Aged; Risk Assessment; Risk Factors; Thromboembolism; Venous Thrombosis

2003

Trials

1 trial(s) available for cyproterone acetate and Venous Thrombosis

Article	Year
Pregnane progestin contraception in systemic lupus erythematosus: a longitudinal study of 187 patients. Contraception, 2011, Volume: 83, Issue:3 Topics: Adolescent; Adult; Androgen Antagonists; Antibodies, Antiphospholipid; Chi-Square Distribution; Chlormadinone Acetate; Cohort Studies; Contraception; Cyproterone Acetate; Female; Humans; Longitudinal Studies; Lupus Erythematosus, Systemic; Middle Aged; Prospective Studies; Venous Thrombosis; Young Adult	2011

Article

Year

Pregnane progestin contraception in systemic lupus erythematosus: a longitudinal study of 187 patients.

Contraception, 2011, Volume: 83, Issue:3

Topics: Adolescent; Adult; Androgen Antagonists; Antibodies, Antiphospholipid; Chi-Square Distribution; Chlormadinone Acetate; Cohort Studies; Contraception; Cyproterone Acetate; Female; Humans; Longitudinal Studies; Lupus Erythematosus, Systemic; Middle Aged; Prospective Studies; Venous Thrombosis; Young Adult

2011

Other Studies

16 other study(ies) available for cyproterone acetate and Venous Thrombosis

Article	Year
Risk of venous thrombosis associated with different types of combined oral contraceptive preparations. Polskie Archiwum Medycyny Wewnetrznej, 2014, Volume: 124, Issue:3 Topics: Contraceptives, Oral, Combined; Cyproterone Acetate; Female; Humans; Risk Assessment; Venous Thrombosis	2014
Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol. The journal of sexual medicine, 2016, Volume: 13, Issue:11 Topics: Administration, Oral; Adult; Androgen Antagonists; Cyproterone Acetate; District of Columbia; Estradiol; Estrogens; Europe; Female; Gender Identity; Gonadal Steroid Hormones; Humans; Incidence; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Retrospective Studies; Risk Factors; Spironolactone; Transgender Persons; Transsexualism; Venous Thrombosis	2016
Thyroid vein thrombosis in a young woman with methylenetetrahydrofolate reductase gene mutation receiving cyproterone acetate/ethinylestradiol treatment for polycystic ovary syndrome: a case report. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2011, Volume: 22, Issue:4 Topics: Adult; Anticoagulants; Contraceptives, Oral, Combined; Cyproterone Acetate; Ethinyl Estradiol; Female; Heparin, Low-Molecular-Weight; Heterozygote; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Polycystic Ovary Syndrome; Thyroid Gland; Venous Thrombosis	2011
Diane-35 (cyproterone acetate): safety concerns. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2003, Feb-18, Volume: 168, Issue:4 Topics: Androgen Antagonists; Canada; Consumer Product Safety; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Risk Factors; United Kingdom; Venous Thrombosis; Women's Health	2003
The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case-control study. Human reproduction (Oxford, England), 2003, Volume: 18, Issue:3 Topics: Acne Vulgaris; Adult; Androgen Antagonists; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Humans; Odds Ratio; Polycystic Ovary Syndrome; Risk Factors; Thromboembolism; Venous Thrombosis	2003
Too much disclosure of product risks? CBC television, SOGC, and Diane-35. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2003, Volume: 25, Issue:4 Topics: Acne Vulgaris; Advertising; Androgen Antagonists; Canada; Cyproterone Acetate; Disclosure; Drug Combinations; Ethinyl Estradiol; Female; Humans; Odds Ratio; Risk Factors; United States; Venous Thrombosis	2003
First-use risks. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2003, May-27, Volume: 168, Issue:11 Topics: Androgen Antagonists; Canada; Consumer Product Safety; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Risk Assessment; Risk Factors; Thromboembolism; Venous Thrombosis	2003
Absolute and attributable risk of venous thromboembolism in women on combined cyproterone acetate and ethinylestradiol. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2003, Volume: 25, Issue:7 Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Cyproterone Acetate; Denmark; Epidemiologic Studies; Ethinyl Estradiol; Female; Humans; Risk Assessment; Risk Factors; Thromboembolism; Venous Thrombosis	2003
Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:12 Topics: Activated Protein C Resistance; Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Estrogens; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Hemostasis; Hormones; Humans; Male; Sex Characteristics; Testosterone; Transsexualism; Venous Thrombosis	2003
Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2004, Volume: 26, Issue:5 Topics: Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Risk Factors; Venous Thrombosis	2004
Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database. Pharmacoepidemiology and drug safety, 2004, Volume: 13, Issue:7 Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Case-Control Studies; Cyproterone Acetate; Databases, Factual; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Incidence; Polycystic Ovary Syndrome; United Kingdom; Venous Thrombosis	2004
Specific oral contraceptive use and venous thromboembolism resulting in hospital admission. The New Zealand medical journal, 2004, Nov-26, Volume: 117, Issue:1206 Topics: Adolescent; Adult; Androgen Antagonists; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Utilization; Ethinyl Estradiol; Humans; Middle Aged; Progestins; Pulmonary Embolism; Retrospective Studies; Venous Thrombosis	2004
Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2004, Volume: 26, Issue:6 Topics: Contraceptives, Oral, Combined; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Risk Factors; Safety; Venous Thrombosis	2004
Venous thromboembolism and cyproterone acetate in men with prostate cancer: a study using the General Practice Research Database. BJU international, 2007, Volume: 99, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Case-Control Studies; Cohort Studies; Cyproterone Acetate; Databases as Topic; Family Practice; Humans; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Risk Factors; Severity of Illness Index; Survival Analysis; Thromboembolism; Venous Thrombosis	2007
Risk of venous thromboembolism and oral contraceptives. Lancet (London, England), 2002, Apr-13, Volume: 359, Issue:9314 Topics: Androgen Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Contraceptives, Oral; Cyproterone Acetate; Female; Humans; Lupus Erythematosus, Systemic; Risk Factors; Venous Thrombosis	2002
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills? Acta obstetricia et gynecologica Scandinavica, 2002, Volume: 81, Issue:6 Topics: Biomarkers; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Predictive Value of Tests; Risk Factors; Sex Hormone-Binding Globulin; Venous Thrombosis	2002